Skip to main content
NC3Rs: National Centre for the Replacement Refinement & Reduction of Animals in Research
News

Antibody Champions recruited to deliver 3Rs impact across the UK

Three early career researchers talking at a table

Working with the Only Good Antibodies (OGA) community we have recruited 16 early career researchers who will drive the validation and use of better antibodies. 

Batch-to-batch variation in animal-derived antibodies impacts target specificity and reproducibility between experiments. Experiments which give inaccurate results or are not reproducible delay scientific progress and drug development pipelines and lead to the unnecessary use of animals in vivo studies that are based on unreliable in vitro data.

To tackle this issue the joint OGA/NC3Rs Antibody Champions scheme has recruited 16 early career researchers to help drive the validation and use of high-quality antibodies across the research community. The Champions are based across the UK and work across a range of disciplines, from stroke-on-a-chip and stem cell dementia models to snake venom biology and kidney imaging. 

Over the 12-month programme, Antibody Champions will be given training in antibody selection and validation, ensuring that antibodies selected for use are the most likely to give accurate and reproducible results. They will take this knowledge back to their own institutions, providing guidance and promoting best practice locally. This will include highlighting the advantages of using non-animal derived antibodies over traditional monoclonal/polyclonal antibodies, and how to search for or generate antibody validation data. The first meeting will take place this week and we look forward to welcoming the Champions to the programme.

Find out more about the OGA/NC3Rs Antibody Champions: